SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
Datum | Rating | Analyst | |
---|---|---|---|
18.08.11 | Basilea Pharmaceutica hold | Vontobel Research | |
17.08.11 | Straumann hold | Vontobel Research | |
16.08.11 | Novartis neutral | Goldman Sachs Group Inc. | |
16.08.11 | Straumann hold | Citigroup Corp. | |
16.08.11 | Straumann hold | Vontobel Research | |
12.08.11 | Straumann hold | Citigroup Corp. | |
12.08.11 | COLTENE buy | Vontobel Research | |
11.08.11 | Straumann hold | Vontobel Research | |
11.08.11 | Lonza hold | Vontobel Research | |
10.08.11 | Lonza hold | Vontobel Research | |
09.08.11 | Novartis buy | Nomura | |
01.08.11 | Lonza hold | Citigroup Corp. | |
29.07.11 | Newron PharmaceuticalsAz. buy | Vontobel Research | |
28.07.11 | Lonza hold | Vontobel Research | |
27.07.11 | Lonza hold | Citigroup Corp. | |
27.07.11 | Novartis kaufen | Raiffeisen Centrobank AG | |
25.07.11 | Tecan (N) buy | Vontobel Research | |
25.07.11 | Novartis buy | Vontobel Research | |
22.07.11 | Novartis buy | Citigroup Corp. | |
22.07.11 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
20.07.11 | Novartis buy | Citigroup Corp. | |
20.07.11 | Novartis buy | Vontobel Research | |
20.07.11 | Novartis kaufen | Independent Research GmbH | |
19.07.11 | Novartis buy | Citigroup Corp. | |
19.07.11 | Novartis buy | Vontobel Research | |
18.07.11 | Novartis buy | UBS AG | |
18.07.11 | Novartis hold | UniCredit Research | |
15.07.11 | Novartis buy | Nomura | |
15.07.11 | Novartis buy | Société Générale Group S.A. (SG) | |
13.07.11 | Novartis buy | Citigroup Corp. | |
13.07.11 | Lonza hold | Citigroup Corp. | |
11.07.11 | Lonza hold | Citigroup Corp. | |
11.07.11 | Novartis buy | Vontobel Research | |
11.07.11 | Lonza hold | Vontobel Research | |
11.07.11 | Lonza kaufen | Fuchsbriefe | |
08.07.11 | Novartis buy | Vontobel Research | |
07.07.11 | Novartis kaufen | Independent Research GmbH | |
06.07.11 | Novartis overweight | J.P. Morgan Cazenove | |
06.07.11 | Novartis buy | Banc of America Securities-Merrill Lynch | |
05.07.11 | Novartis buy | Vontobel Research |